Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 24, 2020
Improving Academic Biobank Value and Sustainability Through an Outputs FocusAmanda Rush, Daniel R Catchpoole, Rod Ling, et al.
International Immunology|September 22, 2006
Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patientsSharon A Oldford, J Desmond Robb, Dianne Codner, et al.
Biopreservation and Biobanking|June 28, 2024
Incorporating Equity, Diversity and Inclusion in a Canadian BiobankJodi LeBlanc, Tamsin Tarling, Kate Lawrence, et al.
JACC. Cardiovascular Interventions|May 26, 2012
Pathology of transcatheter valve therapyFabian Nietlispach, John G Webb, Jian Ye, et al.
Breast Cancer Research : BCR|December 14, 2011
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancerNathan R West, Katy Milne, Pauline T Truong, et al.
Breast Cancer Research : BCR|June 7, 2008
Jab1 is a target of EGFR signaling in ERalpha-negative breast cancerJiaxu Wang, Rebecca O Barnes, Nathan R West, et al.
Biopreservation and Biobanking|June 24, 2021
Vignettes to Illustrate the Value of Tumor Biobanks in Cancer Research in CanadaTamsin Tarling, Lise Anne Marie Matzke, Amanda Rush, et al.
Cancer Research|July 10, 2007
Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cellsErika M Wall, Katy Milne, Michele L Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
CD103 and Intratumoral Immune Response in Breast CancerZhi-Qiang Wang, Katy Milne, Heather Derocher, et al.
Biopreservation and Biobanking|December 8, 2017
An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating BiobanksRod Ling, Amanda Rush, Candace Carter, et al.
Pageof 12